Novel Tubeimoside I liposomal drug delivery system in combination with gemcitabine for the treatment of pancreatic cancer

被引：0
|
作者：
Li, Shuhui [1 ]
Liu, Yuansheng [2 ]
Sui, Xiaojun [3 ,4 ]
Zhuo, Yuzhen [3 ]
Siqi, He [4 ]
Sijia, Zhang [4 ]
Hui, Zhang [3 ]
Dihua, Li [3 ]
Dapeng, Zhang [3 ]
Lei, Yang [3 ]
机构：
[1] Tianjin Univ Tradit Chinese Med, Sch Tradit Chinese Med, Tianjin 301617, Peoples R China
[2] Tianjin Union Med Ctr, Dept Colorectal Surg, Tianjin 300000, Peoples R China
[3] Tianjin Med Univ, Tianjin Nankai Hosp, Tianjin Key Lab Organ Injury & ITCWM Repair Associ, Tianjin 300100, Peoples R China
[4] Tianjin Med Univ, Grad Sch, Tianjin 300270, Peoples R China
来源：
NANOMEDICINE | 2024年 / 19卷 / 24期
关键词：
F18-FDG micro-PET/CT imaging; gemcitabine; liposomes; pancreatic cancer; tubular alfalfa glycosides I; tumor microenvironment; CHOLESTEROL; PACLITAXEL; SAPONINS; KINETICS; RELEASE;
D O I：
10.1080/17435889.2024.2382076
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To evaluate the anti-pancreatic cancer effect of novel Tubeimoside I multifunctional liposomes combined with gemcitabine. Methods: Liposomes were prepared through the thin film hydration method, with evaluations conducted on parameters including encapsulation efficiency (EE%), particle size, polydispersity index (PDI), zeta potential (ZP), storage stability, and release over a 7-day period. The cellular uptake rate, therapeutic efficacy in vitro and in vivo and the role of immune microenvironment modulation were evaluated. Results: The novel Tubeimoside I multifunctional liposomal exhibited good stability, significant anti-cancer activity, and immune microenvironment remodeling effects. Furthermore, it showed a safety profile. Conclusion: This study underscores the potential of Novel Tubeimoside I multifunctional liposomal as a promising treatment option for pancreatic cancer.
引用
收藏
页码：1977 / 1993
页数：17
相关论文
共 50 条
  • [21] PTEN-Long and gemcitabine combination treatment as a therapeutic for pancreatic cancer
    Ahmed, Roshan Ara
    Hopkins, Benjamin
    Palermo, Carmine
    Sastra, Steve A.
    Rapp, Zachary
    Parsons, Ramon
    Olive, Kenneth P.
    CANCER RESEARCH, 2015, 75
  • [22] Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
    Lei, Fan
    Xi, Xinyuan
    Batra, Surinder K.
    Bronich, Tatiana K.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (03): : 682 - 694
  • [23] PTEN-Long and gemcitabine combination treatment as a therapeutic for pancreatic cancer
    Ahmed, Roshan Ara
    Hopkins, Benjamin
    Palermo, Carmine
    Sastra, Steve A.
    Rapp, Zachary
    Parsons, Ramon
    Olive, Kenneth P.
    CANCER RESEARCH, 2015, 75
  • [24] Targeted liposomal drug delivery in cancer
    Medina, OP
    Zhu, Y
    Kairemo, K
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (24) : 2981 - 2989
  • [25] A review on liposomal drug delivery system
    Muralikrishnan, R.
    Selvamuthukumar, R.
    Mohankumar, A.
    Praveen, K.
    Swamivelmanickam, M.
    Sivakrishnan, S.
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2020, 15 (08): : 124 - 135
  • [26] An Overview on Liposomal Drug Delivery System
    Chandran, Subash M. P.
    Prasobh, G. R.
    Jaghatha, T.
    Aswathy, B. S.
    Remya, S. B.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND PHYTOPHARMACOLOGICAL RESEARCH, 2019, 9 (02): : 61 - 68
  • [27] A novel way to sensitize pancreatic cancer cells for gemcitabine treatment
    Xie, Jingwu
    Gu, Dongsheng
    Zhang, Xiaoli
    Jia, Yanfei
    Chiorean, Gabi
    CANCER RESEARCH, 2016, 76
  • [28] Development and evaluation of novel gemcitabine analog for the treatment of pancreatic cancer
    Okoro, Joy
    Bulusu, Raviteja
    Frimpong, Esther K.
    Rodgers, Sherise
    Han, Bo
    Zhu, Xue
    Agyare, Edward
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Peptide conjugated liposomal formulation for anticancer drug delivery: a novel approach towards efficient cancer treatment
    Rajyaguru, T.
    Ukawala, M.
    Pimple, S.
    Murthy, R. S. R.
    Gude, R. P.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 : A72 - A72
  • [30] Gemcitabine Combination Nano Therapies for Pancreatic Cancer
    Samanta, Kamalika
    Setua, Saini
    Kumari, Sonam
    Jaggi, Meena
    Yallapu, Murali M.
    Chauhan, Subhash C.
    PHARMACEUTICS, 2019, 11 (11)
12345